KORU Medical Systems Inc
For the period ended Dec 31, 2023. Filed Mar 13, 2024.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2023 · Filed Mar 13, 2024
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Signatures
Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized on March 13, 2024.
KORU MEDICAL SYSTEMS, INC.
/s/ Linda Tharby
Linda Tharby, President and Chief Executive Officer
/s/ Thomas Adams
Thomas Adams, Chief Financial Officer and Treasurer
Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the Registrant and in the capacities indicated on March 13, 2024.
/s/ R. John Fletcher
R. John Fletcher, Chairman of the Board
/s/ Edward Wholihan
Edward Wholihan, Director
/s/ Robert A. Casella
Robert A. Casella, Director
/s/ Joseph M. Manko, Jr.
Joseph M. Manko, Jr., Director
/s/ Shahriar Matin
Shahriar Matin, Director
/s/ Donna French
Donna French, Director
/s/ Linda Tharby
Linda Tharby, Director
- 53 -
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.